Abstract:Bioactive peptides derived from food are promising health-promoting ingredients that can be used in functional foods and nutraceutical formulations. In addition to potency towards the selected therapeutic target, the bioavailability of bioactive peptides is a major factor regarding clinical efficacy. We have previously shown that a low molecular weight peptide fraction (LMWPF) from poultry by-product hydrolysate possesses angiotensin-1-converting enzyme (ACE-1) and dipeptidyl-peptidase 4 (DPP4) inhibitory activity. The present study aimed to investigate the bioavailability of the bioactive peptides in the LMWPF. Prior to investigation of bioavailability, a dipeptide YA was identified from this fraction as a dual inhibitor of ACE-1 and DPP4. Gastrointestinal (GI) stability and intestinal absorption of the bioactive peptides (i.e., YA as well as two previously reported bioactive dipeptides (VL and IY)) in LMWPF were evaluated using INFOGEST static in vitro digestion model and an intestinal Caco-2 cell monolayer, respectively. Analysis of peptides after in vitro digestion confirmed that the dipeptides were resistant to the simulated GI conditions. After 4 hours of incubation, the concentration of peptide from the apical side of the Caco-2 cell monolayer showed a significant decrease. However, the corresponding absorbed peptides were not detected on the basolateral side, suggesting that the peptides were not transported across the intestinal monolayer but rather taken up or metabolized by the Caco2 cells.Furthermore, when analyzing the gene expression of the Caco-2 cells upon peptide stimulation, a down-regulation of peptide transporters, the transcription factor CDX2, and the tight junction protein-1 (TJP1) were observed, suggesting specific effects of the peptides on the Caco-2 cells. The study demonstrated that bioactive dipeptides found in LMWPF were stable through in vitro GI digestion, however, the overall bioavailability may be hindered by inadequate uptake across the intestinal barrier.

Evaluation of the multifunctional dipeptidyl-peptidase IV and angiotensin converting enzyme inhibitory properties of a casein hydrolysate using cell-free and cell-based assays

Integrated Evaluation of the Multifunctional DPP-IV and ACE Inhibitory Effect of Soybean and Pea Protein Hydrolysates

In Vitro and in Silico Analysis of Dual-Function Peptides Derived from Casein Hydrolysate

Anti-diabetic Mechanism and Potential Bioactive Peptides of Casein Hydrolysates in STZ/HFD-induced Diabetic Rats

Integrated Evaluation of Dual-Functional DPP-IV and ACE Inhibitory Effects of Peptides Derived from Sericin Hydrolysis and Their Stabilities during In Vitro-Simulated Gastrointestinal and Plasmin Digestions

In vitro gastrointestinal stability and intestinal absorption of ACE-1 and DPP4 inhibitory peptides from poultry by-product hydrolysate

Susceptibility of Milk Protein-Derived Peptides to Dipeptidyl Peptidase Iv (Dpp-Iv) Hydrolysis

Production, Analysis and in Vivo Evaluation of Novel Angiotensin-I-converting Enzyme Inhibitory Peptides from Bovine Casein

Gel-Forming of Self-Assembling Peptides Functionalized with Food Bioactive Motifs Modulate DPP-IV and ACE Inhibitory Activity in Human Intestinal Caco-2 Cells

Enzymatic Hydrolysis of Buffalo Casein Enhances DPP-4 Inhibition: Structural Modifications and Bioactive Peptide Identification

Enzymatic Characterization and Synergistic Effects of Protease Combinations on DPP-IV Inhibitory Peptide Release from Bovine Casein

Characterization and Evaluation of the in Vitro and in Vivo Anti-Diabetic Activities of Camel Milk Protein Hydrolysates Derived with Different Protease Digestions

The development of bioactive peptides from dietary proteins as a dipeptidyl peptidase IV inhibitor for the management of type 2 diabetes

Analysis And Evaluation Of The Inhibitory Mechanism Of A Novel Angiotensin-I-Converting Enzyme Inhibitory Peptide Derived From Casein Hydrolysate

Identification and Analysis of Transepithelial Transport Properties of Casein Peptides with Anticoagulant and ACE Inhibitory Activities

Identification and In Silico Analysis of ACE-Inhibitory Peptides Derived from Milk Fermented by Lacticaseibacillus paracasei

Identification, Screening, and Comprehensive Evaluation of Novel DPP-IV Inhibitory Peptides from the Tilapia Skin Gelatin Hydrolysate Produced Using Ginger Protease

Mechanistic Study of Novel Dipeptidyl Peptidase IV Inhibitory Peptides from Goat’s Milk Based on Peptidomics and in Silico Analysis

Exploring the Antidiabetic and Antihypertensive Potential of Peptides Derived from Bitter Melon Seed Hydrolysate

Angiotensin Converting Enzyme (ACE) Inhibitory Peptides: Production and Implementation of Functional Food

In Silico Hydrolysis of Lupin (Lupinus angustifolius L.) Conglutins with Plant Proteases Releases Antihypertensive and Antidiabetic Peptides That Are Bioavailable, Non-Toxic, and Gastrointestinal Digestion Stable